Clinical Research

Relationship of serum ANGPTL3 and NFATc1 levels with the severity and prognosis in cerebral infarction patients

  • Zijuan FU ,
  • Qian LI ,
  • Lin LU ,
  • Yongqiu. LI
Expand
  • Department of Neurology,Tangshan Workers' Hospital,North China University of Science and Technology,Tangshan 063000,China

Received date: 2023-09-06

  Online published: 2024-05-21

Abstract

Objective To investigate the serum levels of angiopoietin-like protein-3 (ANGPTL3) and nuclear factor of active T cells cytoplasmic 1 (NFATc1) in patients with cerebral infarction, and their relationship with the severity and prognosis of the disease. Methods A total of 180 patients with cerebral infarction set as cerebral infarction group who underwent treatment in our hospital from January 2021 to January 2023 were collected as research subjects. According to the NIHSS score, the patients were divided into mild group (n = 68), moderate group (n = 76), and severe group (n = 36), respectively. According to the mRS Score, they were divided into a good prognosis group (n = 117) and a poor prognosis group (n = 63). Another 180 healthy people were enrolled as the control group. The levels of serum ANGPTL3 and NFATc1 were compared among the groups. Multivariate logistic regression was adopted to analyze the influencing factors of prognosis in the patients with cerebral infarction. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of serum ANGPTL3 and NFATc1 on the prognosis of the patients with cerebral infarction. Results The serum levels of ANGPTL3 and NFATc1 in the cerebral infarction group were significantly higher than those in the control group (P < 0.05). The levels of serum ANGPTL3 and NFATc1 were significantly increased in an ascending order across the mild, moderate, and severe groups (P < 0.05). The volume of cerebral infarction, white blood cell count, ANGPTL3, and NFATc1 levels in the patients with poor prognosis were significantly higher than those in the patients with good prognosis (P < 0.05). Regression analysis showed that cerebral infarction volume, white blood cell count, ANGPTL3, and NFATc1 were the influencing factors of the prognosis of cerebral infarction patients (P < 0.05). The levels of ANGPTL3 and NFATc1 together were more effective than they were alone in predicting the prognosis of the patients with cerebral infarction (Z combined detection - ANGPTL3 = 3.345, Zcombined detection - NFATc1 = 2.898; P = 0.001, 0.004). Conclusion The serum levels of ANGPTL3 and NFATc1 in patients with cerebral infarction are significantly increased, with the increase amplitude depending on the severity of the condition. ANGPTL3 and NFATc1, when combined, are more effective and valuable for predicting the prognosis of cerebral infarction patients.

Cite this article

Zijuan FU , Qian LI , Lin LU , Yongqiu. LI . Relationship of serum ANGPTL3 and NFATc1 levels with the severity and prognosis in cerebral infarction patients[J]. The Journal of Practical Medicine, 2024 , 40(10) : 1407 -1411 . DOI: 10.3969/j.issn.1006-5725.2024.10.013

References

1 ZHAO Y, ZHANG X, CHEN X, et al. Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)[J]. Int J Mol Med, 2022, 49(2):15-23. doi:10.3892/ijmm.2021.5070
2 闫欣,王曼,高阳,等. 全膝关节置换术围手术期脑梗死危险因素及预后分析[J]. 实用医学杂志,2020,36(21):2942-2946. doi:10.3969/j.issn.1006-5725.2020.21.011
3 LIU X, BAI M, FAN L, et al. Serum 4-hydroxynonenal associates with the recurrence of patients with primary cerebral infarction[J]. Front Cell Neurosci, 2022, 6(2):998512-998519.
4 KERSTEN S. ANGPTL3 as therapeutic target[J]. Curr Opin Lipidol, 2021, 32(6):335-341. doi:10.1097/mol.0000000000000789
5 WANG J, ZHENG H, MA R. Natural Occurring Compounds Inhibit Osteoclastogenesis via Targeting NFATc1-related Signaling Pathways[J]. Curr Drug Targets, 2020, 21(4):358-364. doi:10.2174/1389450120666191017121610
6 LYDEN P. Using the National Institutes of Health Stroke Scale: A Cautionary Tale[J]. Stroke, 2017, 48(2):513-519. doi:10.1161/strokeaha.116.015434
7 刘志薇,张振香,梅永霞,等. 脑卒中患者配偶照顾者抑郁症状潜在类别分析及影响因素[J]. 军事护理,2023,40(4):56-59+107.
8 高长玉,吴成翰,赵建国,等. 中国脑梗死中西医结合诊治指南(2017)[J].中国中西医结合杂志,2018,38(2):136-144. doi:10.7661/j.cjim.20171221.483
9 WANG R, ZHONG Y, ZHOU Q, et al. Relationship between Uric Acid Level and Severity of Acute Primary Cerebral Infarction: A Cross-Sectional Study[J]. Biomed Res Int, 2020, 1(1):2310307-2310313.
10 郭晓斌,刘苹,杨浩辉,等. 老年高血压人群身高与新发脑梗死关系[J]. 实用医学杂志,2023,39(13):1714-1718. doi:10.3969/j.issn.1006-5725.2023.13.021
11 SUN T, ZHAN W, WEI L, et al. Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity[J]. Lipids Health Dis, 2021, 20(1):154-162. doi:10.1186/s12944-021-01580-z
12 LV Q, JIAO X, YU H, et al. ANGPTL3 and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea[J]. J Am Heart Assoc, 2022, 11(18):025955-025973. doi:10.1161/jaha.122.025955
13 GUO X, HUANG Z, CHEN J, et al. ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease[J]. Front Cardiovasc Med, 2022, 9(1):913363-13374. doi:10.3389/fcvm.2022.913363
14 XU F, SHEN L, YANG Y, et al. Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension[J]. Diabetes Metab Syndr Obes, 2023, 16(1):1647-1655. doi:10.2147/dmso.s411483
15 LIU Y, WANG C, WANG G, et al. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities[J]. Theranostics, 2019, 9(16):4648-4662. doi:10.7150/thno.35414
16 LATIF M U, SCHMIDT G E, Mercan S, et al. NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression[J]. Gut, 2022, 71(12):2561-2573. doi:10.1136/gutjnl-2021-325013
17 GOVATATI S, PICHAVARAM P, JANJANAM J, et al. NFATc1-E2F1-LMCD1-Mediated IL-33 Expression by Thrombin Is Required for Injury-Induced Neointima Formation[J]. Arterioscler Thromb Vasc Biol, 2019, 39(6):1212-1226. doi:10.1161/atvbaha.119.312729
18 LU P, ZHANG D, DING F, et al. Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis[J]. Cells, 2023, 12(12):1667. doi:10.3390/cells12121667
19 谢尊椿,刘彬,周美鸿,等. 急性缺血性脑卒中患者血浆miR-124表达变化及其意义[J]. 实用医学杂志,2019,35(3):343-345. doi:10.3969/j.issn.1006-5725.2019.03.002
Outlines

/